Results 191 to 200 of about 410,300 (316)

Noninvasive tests for nonalcoholic fatty liver disease in a multi‐ethnic population: The HELIUS study

open access: yesHepatology Communications, EarlyView., 2022
Abstract Nonalcoholic fatty liver disease (NAFLD) is increasing in prevalence and severity globally, prompting noninvasive testing, yet limited data exist on noninvasive liver tests (NITs) including transient elastography (TE) in ethnically diverse populations.
Anne‐Marieke van Dijk   +6 more
wiley   +1 more source

Management and Modification of Flavonoids Against Nonalcoholic Fatty Liver Disease

open access: yesFood Bioengineering, EarlyView.
Flavonoids protect against NAFLD by enhancing mitochondrial function, reducing ER stress, and modulating gut microbiota. Structural modifications improve flavonoid efficacy, offering a promising dietary strategy for NAFLD management. ABSTRACT Flavonoids are small bioactive molecules commonly found in plant‐derived foods, exhibiting antioxidant, anti ...
Weidong Bai   +6 more
wiley   +1 more source

Sulfated Polysaccharides in the Hallmarks of Metabolic Syndrome: Functions and Mechanisms

open access: yesFood Frontiers, EarlyView.
The SPs sources are very diverse, including various fishes, sea cucumbers, seaweeds, etc. These SPs are able to improve the glucose and lipid metabolism disorders, hormonal dysregulation, oxidative stress, inflammatory response, complications, and gut homeostasis of MetS by regulating biochemical indicators related to MetS. ABSTRACT Metabolic syndrome (
Fuqiang Zhao   +9 more
wiley   +1 more source

Selenium‐Enriched Matcha Ameliorates Alcohol‐Induced Liver Injury by Modulating Cytochrome P450 Expression in Mice

open access: yesFood Frontiers, EarlyView.
ABSTRACT Selenium is an essential trace element for human health, and the selenium content in selenium‐enriched matcha meets the official criteria for selenium‐enriched foods in China. In the present work, hepatoprotective effects of selenium‐enriched matcha against alcohol‐induced liver injury were systematically investigated, and its mechanism was ...
Zhuo‐Wen Su   +5 more
wiley   +1 more source

Influence of DAA treatment in patients with HCV-cirrhosis and esophageal varices on liver transplant free survival and risk of developing hepatocellular carcinoma

open access: bronze, 2020
Noelia Rodríguez Ferreiro   +9 more
openalex   +1 more source

The role of atrial natriuretic peptide (ANP) in chronic liver disease. [PDF]

open access: yes, 1993
Almeida   +82 more
core   +1 more source

Investigation of Ornithine Carbamoyltransferase as a Biomarker of Liver Cirrhosis

open access: diamond, 2014
Noriko Matsushita   +9 more
openalex   +2 more sources

Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury [PDF]

open access: gold, 2022
Irina Gîrleanu   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy